TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
TRAVELING THE WORLD, WRITING WHAT THE PEOPLE NEED TO KNOW.
Who gets to write the history textbooks? Where do the history teachers learn about history? What documents are allowed into the historical record, and what documents are excluded? These are not merely academic questions, they go right to the heart of the question of history itself. Join James Corbett for today’s edition of The Corbett Read More…
Why do mainstream media reporters within ostensibly free democracies act just like state media propagandists? Why are they so reliably pro-establishment, all throughout every mainstream outlet? Why do they so consistently marginalize any idea that doesn’t fit within the extremely narrow Overton window of acceptable opinion?Why does anyone who inconveniences western establishment power always find Read More…
When even the Washington Post is saying your Russiagate article is bad journalism, your Russiagate article is really, really bad journalism. In an article titled “The Guardian offered a bombshell story about Paul Manafort. It still hasn’t detonated.”, WaPo writer Pul Farhi draws attention to the fact that it has been a week since the Guardian published a claim that former Trump Read More…
For the first few hours after any new “bombshell” Russiagate story comes out, my social media notifications always light up with poorly written posts by liberal establishment loyalists saying things like “HAHAHA @caitoz this proves you wrong now will you FINALLY stop denying Russian collusion???” Then, when people start actually analyzing that story and noting Read More…
“As part of the plea bargain, Purdue agreed to pay the federal government $600 million and 27 states $20 million. The three executives agreed to $34.5 million in fines but avoided jail-time. By contrast, Purdue has earned an estimated $31 billion in total revenues from extended-release oxycodone since its launch. Rather than deterring fraudulent marketing, Read More…
Certain especially vulnerable groups, such as Iran’s cancer patients, are bearing the brunt of the burden caused by the new U.S.-imposed sanctions, as the cost of the average cancer treatment has now doubled and the supply of crucial medication has dwindled to new, troubling lows. TEHRAN, IRAN – The recent imposition of crippling sanctions against Iran Read More…